Cargando…

The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis

BACKGROUNDS: While previous meta-analysis have investigated the efficacy of cilostazol in the secondary prevention of ischemic stroke, they were criticized for their methodology, which confused the acute and chronic phases of stroke. We present a new systematic review, which differs from previous me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, LiGen, Pu, JiaLi, Xu, Liang, Malaguit, Jay, Zhang, Jianmin, Chen, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301843/ https://www.ncbi.nlm.nih.gov/pubmed/25527141 http://dx.doi.org/10.1186/s12883-014-0251-7

Ejemplares similares

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke
por: Lee, Su-Yun, et al.
Publicado: (2008)

The Efficacy and Safety of Cilostazol vs. Aspirin for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis
por: Chai, Erqing, et al.
Publicado: (2022)

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
por: Galyfos, George, et al.
Publicado: (2017)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
por: Tan, Choon Han, et al.
Publicado: (2021)

Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study
por: Lee, Tsong-Hai, et al.
Publicado: (2020)

Systematic study of cilostazol on secondary stroke prevention: a meta-analysis
por: Qian, Yining, et al.
Publicado: (2013)

Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients
por: Heo, Sung Hyuk, et al.
Publicado: (2012)

Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis
por: McHutchison, Caroline, et al.
Publicado: (2020)

Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study
por: Senda, Joe, et al.
Publicado: (2019)

Retraction Note: Systematic study of cilostazol on secondary stroke prevention: a meta-analysis
por: Qian, Yining, et al.
Publicado: (2015)

Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke
por: Zhou, Lily W., et al.
Publicado: (2022)

Effects of cilostazol on the progression and regression of symptomatic intracranial artery stenosis: it reduces the risk of ischemic stroke
por: Zhang, Wen-hui, et al.
Publicado: (2015)

Safety and efficacy of cilostazol in the management of intermittent claudication
por: Chi, Yung-Wei, et al.
Publicado: (2008)

Cilostazol minimizes venous ischemic injury in diabetic and normal rats
por: Wajima, Daisuke, et al.
Publicado: (2011)

Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials
por: Wang, Zefeng, et al.
Publicado: (2017)

Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke
por: Kim, Yu Ri, et al.
Publicado: (2017)

Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation
por: Liu, Hui, et al.
Publicado: (2023)

Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model
por: Nagai, Noriaki, et al.
Publicado: (2015)

Desmoteplase for Acute Ischemic Stroke within 3 to 9 Hours after Symptom Onset: Evidence from Randomized Controlled Trials
por: Shi, Ligen, et al.
Publicado: (2016)

A novel phenotype of B cells associated with enhanced phagocytic capability and chemotactic function after ischemic stroke
por: Wang, Rui, et al.
Publicado: (2023)

Impact of hyperlipidemia and atrial fibrillation on the efficacy of endovascular treatment for acute ischemic stroke: a meta-analysis
por: Zheng, Jingwei, et al.
Publicado: (2017)

Effectiveness of cilostazol in transient ischemic attack refractory to aspirin: A report of two cases
por: LIN, GAOPING, et al.
Publicado: (2014)

Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com
por: Hoshino, Haruhiko, et al.
Publicado: (2023)

Ischemic Stroke Subtype Classification: An Asian Viewpoint
por: Kim, Bum Joon, et al.
Publicado: (2014)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
por: Kalantzi, Kallirroi, et al.
Publicado: (2020)

Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation
por: Sun, Fei, et al.
Publicado: (2015)

Targeting neuronal mitophagy in ischemic stroke: an update
por: Li, Jun, et al.
Publicado: (2023)

Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes
por: Leeper, Nicholas J., et al.
Publicado: (2013)

Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial
por: Saito, Satoshi, et al.
Publicado: (2023)

Considerations When Subtyping Ischemic Stroke in Asian Patients
por: Bang, Oh Young
Publicado: (2016)

Angiotensinogen gene polymorphism and ischemic stroke in East Asians: A meta-analysis☆
por: Wang, Sheng, et al.
Publicado: (2013)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Review of Toyoda K, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischemic stroke in Japan. Lancet Neurol. 2019 Jun;18(6):539-548
por: Lo, Benjamin W. Y., et al.
Publicado: (2020)

Intratumoral Hemorrhage in a Patient With Cerebellar Hemangioblastoma: A Case Report and Review
por: Wang, Zhen, et al.
Publicado: (2015)

Adenoviral TMBIM6 vector attenuates ER-stress-induced apoptosis in a neonatal hypoxic-ischemic rat model
por: Doycheva, Desislava, et al.
Publicado: (2019)

Comparison of Traditional Chinese Medicine in the Long-Term Secondary Prevention for Patients with Ischemic Stroke: A Systematical Analysis
por: Li, Jiali, et al.
Publicado: (2021)

Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research
por: Reis, Cesar, et al.
Publicado: (2017)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
por: Uchiyama, Shinichiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1gjafgl2g69q0ae87tqrq4g57c